BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Limanskiy V, Vyas A, Chaturvedi LS, Vyas D. Harnessing the potential of gene editing technology using CRISPR in inflammatory bowel disease. World J Gastroenterol 2019; 25(18): 2177-2187 [PMID: 31143069 DOI: 10.3748/wjg.v25.i18.2177]
URL: https://www.wjgnet.com/1007-9327/full/v25/i18/2177.htm
Number Citing Articles
1
Rui Wang, Sean Graham, Ning Sun, Donna McCarthy, Ruoqi Peng, Jamie Erickson, Liz Oconnor, Xiaochun Zhu, Marc Wurbel, Robert Dunstan, Susan Westmoreland, Namjin Chung, Tariq Ghayur, Jijie Gu, Edda Fiebiger. CRISPR/Cas9-targeting of CD40 in hematopoietic stem cells limits immune activation mediated by anti-CD40PLOS ONE 2020; 15(3): e0228221 doi: 10.1371/journal.pone.0228221
2
Aravind Sundararaman, Prakash M. Halami. Genome editing of probiotic bacteria: present status and future prospectsBiologia 2022;  doi: 10.1007/s11756-022-01049-z
3
Miao Wu, Niandan Hu, Xianjin Du, Jie Wei. Application of CRISPR/Cas9 technology in sepsis researchBriefings in Functional Genomics 2020; 19(3): 229 doi: 10.1093/bfgp/elz040
4
Martina Poletti, Kaline Arnauts, Marc Ferrante, Tamas Korcsmaros. Organoid-based Models to Study the Role of Host-microbiota Interactions in IBDJournal of Crohn's and Colitis 2021; 15(7): 1222 doi: 10.1093/ecco-jcc/jjaa257
5
Yiyi Yang, Xiaowen Cheng. The Intestine2021; : 75 doi: 10.1016/B978-0-12-821269-1.00011-4